삼성서울병원

Ko En

Radiation Oncology Park, Hee Chul M.D

Expertise
Liver cancer, biliary and pancreatic cancer, rectal cancer, radiation therapy, proton therapy
Treament Schedule 10 月
DATE
TUE
01
WEB
02
THU
03
FRI
04
SAT
05
SUN
06
MON
07
TUE
08
WEB
09
THU
10
FRI
11
SAT
12
SUN
13
MON
14
TUE
15
WEB
16
THU
17
FRI
18
SAT
19
SUN
20
MON
21
TUE
22
WEB
23
THU
24
FRI
25
SAT
26
SUN
27
MON
28
TUE
29
WEB
30
THU
31
AM
PM
Treament Schedule 11 月
DATE
FRI
01
SAT
02
SUN
03
MON
04
TUE
05
WEB
06
THU
07
FRI
08
SAT
09
SUN
10
MON
11
TUE
12
WEB
13
THU
14
FRI
15
SAT
16
SUN
17
MON
18
TUE
19
WEB
20
THU
21
FRI
22
SAT
23
SUN
24
MON
25
TUE
26
WEB
27
THU
28
FRI
29
SAT
30
AM
PM

Medical Education

2002~2004 Ph.D. in Medicine Yonsei University, Korea
1999~2001 Master of Science Yonsei University, Korea
1986~1992 Medical Doctor College of Medicine, Yonsei University, Korea

Post-Graduate Training

Fellowship   2001~2001 Department of Radiation Oncology, Yonsei University College of Medicine, Korea
Residency   1996~2000 Department of Radiation Oncology, Severance Hospital, Korea
Internship   1992~1993 Severance Hospital, Korea

Professional Appointments

2021~Present Chair Department of Radiation Oncology, Samsung Medical Center
2016~Present Professor Department of Radiation Oncology, Sungkyunkwan University School of Medicine
2010~2015 Associate Professor Department of Radiation Oncology, Sungkyunkwan University School of Medicine
2006~2007 Visiting Scientist Department of Radiation Oncology, MD Anderson Cancer Center, USA
2006~2006 Honorable Visiting Instructor Department of Radiology, Hokkaido University Hospital, Japan
2001~2005 Assistant Professor Department of Radiation Oncology, Hallym University College of Medicine

Professional Memberships

1996~Present Member The Korean Society for Radiation Oncology
2009~Present Member The Korean Liver Cancer Association
2008~Present Member Korean Society of Medical Oncology

Selected Publications

  • J BONE ONCOL 2021 10.1016/j.jbo.2021.100368 Clinical and dosimetric risk factors for vertebral compression fracture after single-fraction stereotactic body radiation therapy for spine metastases Kim1, H; Pyo, H; Park, HC; Lim, DH; Yu, JI; Park, W; Ahn, YC; Choi, DH; Oh, D; Noh, JM; Cho, WK; Yoo, GS; Jung, SH; Kim, ES; Lee, SH; Park, SJ; Lee, CS
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-90065-1 Diffusion-weighted and dynamic contrast-enhanced magnetic resonance imaging after radiation therapy for bone metastases in patients with hepatocellular carcinoma Lee1, JH; Yoo, GS; Yoon, YC; Park, HC; Kim, HS
    View PubMed
  • INT J MOL SCI 2021 10.3390/ijms22052637 Manganese Ferrite Nanoparticles Enhance the Sensitivity of Hepa1-6 Hepatocellular Carcinoma to Radiation by Remodeling Tumor Microenvironments Shin1, SW; Yang, K; Lee, M; Moon, J; Son, A; Kim, Y; Choi, S; Kim, D; Choi, C; Lee, N; Park, HC
    View PubMed
  • CELLS 2021 10.3390/cells10030554 Downregulation of Mcl-1 by Panobinostat Potentiates Proton Beam Therapy in Hepatocellular Carcinoma Cells Choi1, C; Lee, GH; Son, A; Yoo, GS; Yu, JI; Park, HC
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-82177-5 Clinical importance of the absolute count of neutrophils, lymphocytes, monocytes, and platelets in newly diagnosed hepatocellular carcinoma Yu1, JI; Park, HC; Yoo, GS; Choi, C; Choi, MS; Nam, H; Baek, SY; Park, M
    View PubMed